These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36530547)

  • 1. Prioritization preferences for COVID-19 vaccination are consistent across five countries.
    Munzert S; Ramirez-Ruiz S; Çalı B; Stoetzer LF; Gohdes A; Lowe W
    Humanit Soc Sci Commun; 2022; 9(1):439. PubMed ID: 36530547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who Should Get COVID-19 Vaccine First? A Survey to Evaluate Hospital Workers' Opinion.
    Craxì L; Casuccio A; Amodio E; Restivo V
    Vaccines (Basel); 2021 Feb; 9(3):. PubMed ID: 33668695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public Perspectives on COVID-19 Vaccine Prioritization.
    Persad G; Emanuel EJ; Sangenito S; Glickman A; Phillips S; Largent EA
    JAMA Netw Open; 2021 Apr; 4(4):e217943. PubMed ID: 33835172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public opinion in vaccine allocation priority: who comes first?
    Ceccato I; Di Crosta A; La Malva P; Cannito L; Mammarella N; Palumbo R; Palumbo R; Di Domenico A
    Psychol Health; 2023; 38(9):1194-1214. PubMed ID: 34822253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.
    Duch R; Roope LSJ; Violato M; Fuentes Becerra M; Robinson TS; Bonnefon JF; Friedman J; Loewen PJ; Mamidi P; Melegaro A; Blanco M; Vargas J; Seither J; Candio P; Gibertoni Cruz A; Hua X; Barnett A; Clarke PM
    Proc Natl Acad Sci U S A; 2021 Sep; 118(38):. PubMed ID: 34526400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The perceived deservingness of COVID-19 healthcare in the Netherlands: a conjoint experiment on priority access to intensive care and vaccination.
    Reeskens T; Roosma F; Wanders E
    BMC Public Health; 2021 Mar; 21(1):447. PubMed ID: 33673813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.
    Hughes K; Gogineni V; Lewis C; Deshpande A
    Curr Med Res Opin; 2021 Jun; 37(6):907-909. PubMed ID: 33760673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
    Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
    BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should COVID-19 vaccines be distributed between the Global North and South: a discrete choice experiment in six European countries.
    Steinert JI; Sternberg H; Veltri GA; Büthe T
    Elife; 2022 Oct; 11():. PubMed ID: 36254593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment.
    Darrudi A; Daroudi R; Yunesian M; Akbari Sari A
    Pharmacoecon Open; 2022 Sep; 6(5):669-679. PubMed ID: 35997900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands.
    Mouter N; Boxebeld S; Kessels R; van Wijhe M; de Wit A; Lambooij M; van Exel J
    Value Health; 2022 Aug; 25(8):1290-1297. PubMed ID: 35527162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning Approach.
    Kazemi M; Bragazzi NL; Kong JD
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationing of a scarce life-saving resource: Public preferences for prioritizing COVID-19 vaccination.
    Luyten J; Tubeuf S; Kessels R
    Health Econ; 2022 Feb; 31(2):342-362. PubMed ID: 34787925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States.
    Klumpp M; Monfared IG; Vollmer S
    Vaccine; 2022 Apr; 40(16):2457-2461. PubMed ID: 35305827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.